Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of veterans health affairs data

CONCLUSIONSCetuximab with RT yields inferior OS in comparison with cisplatin for the nonoperative management of stage III to IVb HNSCC. According to this study, cisplatin may be the most appropriate partner for RT in this setting.

Source: Cancer - October 20, 2018 Category: Cancer & Oncology Authors: Joshua M. Bauml, Ravi Vinnakota, Yeun ‐Hee Anna Park, Susan E. Bates, Tito Fojo, Charu Aggarwal, Jessica Di Stefano, Christina Knepley, Sewanti Limaye, Ronac Mamtani, Juan Wisnivesky, Nevena Damjanov, Corey J. Langer, Roger B. Cohen, Keith Tags: Original Article Source Type: research